Skip to menu Skip to content Skip to footer

2025

Journal Article

Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18–55 years: a randomised, double-blind, active comparator, Phase I trial

Chappell, Keith J., Mordant, Francesca L., Amarilla, Alberto A., Modhiran, Naphak, Liang, Benjamin, Li, Zheyi, Lackenby, Julia A., Jaberolansar, Noushin, O’Donnell, Jake, Kienzle, Vivian, Kommajosyula, Varsha, Tardiota, Nicolas, Bennet, Jillian K., Henderson, Christina L., Dalrymple, Rhiannon L., Goh, Justin, Hoger, Kym, Gillard, Marianne, Jones, Martina L., Hughes, Karen, Hughes, Ben, Barnes, James, Reading, Patrick C., Ranasinghe, Charani, Subbarao, Kanta, Munro, Trent P., Young, Paul R. and Watterson, Daniel (2025). Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18–55 years: a randomised, double-blind, active comparator, Phase I trial. The Journal of Infectious Diseases jiaf568. doi: 10.1093/infdis/jiaf568

Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18–55 years: a randomised, double-blind, active comparator, Phase I trial

2025

Journal Article

A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus

Young, Andrew, Kolekar, Sharada, Alvarez Mendoza, Carlos, Jaberolansar, Noushin, Modhiran, Naphak, Webb, Tim, McCuaig, Robert, Kommajosyula, Varsha, Tardiota, Nicolas, Dy, Quimbe, Amarilla, Alberto A., Dalrymple, Rhiannon L., Gillard, Marianne, Dutton, Julie L., Magdalena, Juana, Vandendriessche, Frank, Smal, Jean, Young, Paul R., Watterson, Daniel, Hanon, Emmanuel J. and Chappell, Keith J. (2025). A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus. PLOS Pathogens, 21 (7) e1013312, e1013312-7. doi: 10.1371/journal.ppat.1013312

A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirus

2024

Journal Article

HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors

Tardiota, Nicolas, Jaberolansar, Noushin, Lackenby, Julia A., Chappell, Keith J. and O’Donnell, Jake S. (2024). HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors. Virology Journal, 21 (1) 14, 14. doi: 10.1186/s12985-024-02288-z

HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors

2021

Journal Article

Discrimination of methionine sulfoxide and sulfone by human neutrophil elastase

Leahy, Darren, Grant, Cameron, Jackson, Alex, Duff, Alex, Tardiota, Nicholas, Van Haeften, Jessica, Chen, Xingchen, Peake, Jonathan M., Kruppa, Michael D., Smith, Eliot T., Johnson, David A., Lott, William B. and Harris, Jonathan M. (2021). Discrimination of methionine sulfoxide and sulfone by human neutrophil elastase. Molecules, 26 (17) 5344, 1-13. doi: 10.3390/molecules26175344

Discrimination of methionine sulfoxide and sulfone by human neutrophil elastase